Mechanisms involve stimulation of VEGF and hepatocyte growth factor production along with activation of the Wnt/beta-catenin signaling pathway that drives follicle proliferation
Some preclinical studies have identified GLP-1 receptors in the intestinal epithelium and immune cells, with animal models suggesting potential anti-inflammatory properties of GLP-1 agonists
Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3 signaling
At 8mg, the glucagon receptor stimulation is strong enough to produce the tingling and altered skin sensitivity reported in trials
Two distinct appetite-suppression pathways
Using insurance records from more than 60,000 Americans with type 2 diabetes, we found that about four in 10 patients stopped their GLP-1 medication within the first year, and nearly 6 in 10 had stopped by the end of two years, Sontha said